February 2020

AsiaTIDES 2020


Kyoto, Japan

We are exhibiting at AsiaTIDES 2020.

Come and meet the teams:

LGC Biosearch on booth 8A

LGC Axolabs on booth 28

AsiaTIDES offers separate tracks covering the latest oligonucleotide and peptide development strategies from discovery, nonclinical, clinical and CMC to late-stage development and commercialization. 

2020 Oligonucleotide Track Highlights
  • Alnylam’s Lessons Learned from the Global Approval for Onpattro
  • GSK’s Engineering of Enzymes to Make Oligonucleotides at Large Scale in Water
  • Ionis’ GalNAc Conjugation Process Development
  • Dicerna’s CMC Program Strategy and Clinical Progress Update
  • Toray’s Development of A Novel Method for Manufacturing a Single-stranded Long-chain RNA Oligomer
  • WAVE’s Assessment of Stereochemical Identity, Purity and Stability for a Stereopure Oligonucleotide
2020 Peptide Track Highlights
  • Peptidream’s Recent Advancements of Peptide-drug Conjugates
  • Amgen’s Data Reduction and Visualization Technologies for the Design & Optimization of Therapeutic Peptide and Nucleic Acid Derivates
  • Hiroaki Suga’s Research From Constrained Peptides to Neobiologics
  • Ferring’s Treatment of Non-peptide Related Impurities in Peptide API Manufacturing
  • Neon Therapeutics Development of Personal Neoantigen Cancer Vaccine NEO-PV-01
  • Merck’s Macrocyclization of An All-D Linear Peptide: A Novel Stapled α-Helical Peptide Modality


For more information, or to register please visit: AsiaTIDES